We report an extremely rare case of a 69-year-old man having a retroperitoneal carcinoid tumor associated with multiple endocrine neoplasia (MEN) type 1. The patient whose son and daughter were previously diagnosed with MEN type 1 was admitted to the Department of Endocrinology at our hospital for evaluation of this disorder. Computed tomography (CT) and ultrasonography revealed a parathyroid and retroperitoneal tumor (43 mm x 34 mm). The patient did not consent to surgical management of the tumor; however three years later, a follow-up CT revealed tumor enlargement (55 mm x 50 mm). We were unable to rule out a malignancy, and subsequently resected the tumor. A pathological diagnosis of retroperitoneal carcinoid was made. No local recurrence or metastasis have been observed for 21 months.

Download full-text PDF

Source
http://dx.doi.org/10.5980/jpnjurol.102.735DOI Listing

Publication Analysis

Top Keywords

retroperitoneal carcinoid
12
men type
12
carcinoid tumor
8
tumor associated
8
associated multiple
8
neoplasia men
8
tumor
6
[primary retroperitoneal
4
multiple endcrine
4
endcrine neoplasia
4

Similar Publications

Primary renal neuroendocrine tumors (NETs) are extremely rare among renal malignancies. According to pathological manifestations, carcinoid can be divided into four types: typical carcinoid, atypical carcinoid, large cell and small cell neuroendocrine carcinoma. Primary or secondary retroperitoneal carcinoid is even rarer than renal carcinoid.

View Article and Find Full Text PDF

Background: Retroperitoneal fibrosis, a condition of uncertain origin, is rarely linked to 8% of malignant cases, including breast, lung, gastrointestinal, genitourinary, thyroid, and carcinoid. The mechanism leading to peritoneal fibrosis induced by tumors is not well understood, possibly encompassing direct infiltration of neoplastic cells or the initiation of inflammatory responses prompted by cytokines released by tumor cells. We report a case of breast cancer with renal metastasis and retroperitoneal fibrosis detected using F-FDG PET/CT, providing help for clinical diagnosis and treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Teratomas are rare germ cell tumors that can form from multiple germ layers and can be found in various body locations, including the kidneys.
  • A case study describes a 49-year-old woman who had an asymptomatic teratoma discovered in her right renal hilum that was associated with a carcinoid tumor.
  • The findings show that the tumor was separate from the kidney and urinary tract, offering insights into the unusual relationship between teratomas and carcinoid tumors.
View Article and Find Full Text PDF

Introduction And Importance: Solitary fibrous tumors (SFTs), rare mesenchymal tumors, occur in diverse locations. Retroperitoneal and pelvic SFTs are extremely uncommon, challenging to identify due to vague clinical and radiological features. We present a high-risk SFT case in the retropubic Retzius space.

View Article and Find Full Text PDF

Teratomas from past to the present: A scientometric analysis with global productivity and research trends between 1980 and 2022.

Medicine (Baltimore)

June 2023

Department of Orthopedics and Traumatology, Faculty of Medicine, Hitit University, Corum, Turkey.

Article Synopsis
  • This study is the first bibliometric analysis of teratomas, examining 4209 articles published from 1980 to 2022 to identify global research trends and productivity.
  • Top contributors include the USA leading with 24.7% of publications, followed by Japan and India, with key institutions being the University of California System, University of London, and Harvard University.
  • Most researched topics in teratoma literature focus on various types of teratomas, their diagnosis, treatment methods, and recent research trends, including mature cystic teratoma and ovarian neoplasms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!